JCM | Free Full-Text | The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer | NEJM
Kaplan–Meier plots for disease-free survival (DFS) (A) and overall... | Download Scientific Diagram
Measures of Disease Frequency
TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients | Aging
Survival Analysis Basics - Easy Guides - Wiki - STHDA
Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study - Xin Wu, Binglu Li, Chaoji Zheng, 2022
Disease-free survival curve (Kaplan Meier) associated with clusterin... | Download Scientific Diagram
Progression Free Survival
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study - The Lancet Digital Health
Disease-free survival as a measure of overall survival in resected pancreatic endocrine neoplasms
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer - Annals of Oncology
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival | BMC Cancer | Full Text
A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time | Scientific Reports
View Image
Measures of Disease Frequency
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials - ScienceDirect
312: Survival After Disease Progression of Patients with Locally Advanced Bladder Cancer Previously Treated with Radical Cystect
JPM | Free Full-Text | Local Disease-Free Survival Rate (LSR) Application to Personalize Radiation Therapy Treatments in Breast Cancer Models
xmlinkhub
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics | PLOS ONE
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Disease Free Survival - an overview | ScienceDirect Topics
Progression Free Survival
Methodology to standardize heterogeneous statistical data presentations for combining time-to-event oncologic outcomes | PLOS ONE
